HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Hepatitis B virus reactivation after cessation of prophylaxis with lamivudine in a patient with non-Hodgkins lymphoma treated with chemotherapy and rituximab].

AuthorsSusana Vives, Juan Manuel Sancho, Ramón Planas, Josep Maria Ribera
JournalMedicina clinica (Med Clin (Barc)) Vol. 127 Issue 1 Pg. 39 (Jun 03 2006) ISSN: 0025-7753 [Print] Spain
Vernacular TitleReactivación del virus de la hepatitis B tras cese de la profilaxis con lamivudina en una paciente con linfoma no hodgkiniano tratada con quimioterapia y rituximab.
PMID16796944 (Publication Type: Case Reports, Letter)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Hepatitis B Antigens
  • Reverse Transcriptase Inhibitors
  • Lamivudine
  • Rituximab
Topics
  • Antibodies, Monoclonal (therapeutic use)
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents (therapeutic use)
  • Female
  • Hepatitis B (immunology, prevention & control)
  • Hepatitis B Antigens (blood)
  • Humans
  • Lamivudine (therapeutic use)
  • Lymphoma, Non-Hodgkin (drug therapy, virology)
  • Middle Aged
  • Recurrence
  • Reverse Transcriptase Inhibitors (therapeutic use)
  • Rituximab
  • Virus Activation (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: